STAT5B and pancreatic adenocarcinoma: GBMLGG, KIRC, SKCM, and PAAD patients with low STAT5B expression had worse OS [HR = 0.51 (0.41,0.64), p = 5.4e-9; HR = 0.67 (0.56, 0.80), p = 1.2e-5; HR = 0.75 (0.61, 0.91), p = 3.6e-3; HR = 0.77 (0.60, 0.97), p = 0.03, respectively] than those with high STAT5B expression (Figure 3F).